MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation

The Oncologist
Lisa Pei ChuJonathan W Riess

Abstract

Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum-refractory recurrent oral cavity HNSCC underwent comprehensive genomic profiling (CGP) that identified an activating MET mutation (R1004). The patient was treated with the oral MET tyrosine kinase inhibitor crizotinib with rapid response to treatment.Based on this index case, we determined the frequency of MET alterations in 1,637 HNSCC samples, which had been analyzed with hybrid capture-based CGP performed in the routine course of clinical care. The specimens were sequenced to a median depth of >500× for all coding exons from 182 (version 1, n = 24), 236 (version 2, n = 326), or 315 (version 3, n = 1,287) cancer-related genes, plus select introns from 14 (version 1), 19 (version 2), or 28 (version 3) genes frequently rearranged in cancer. We identified 13 HNSCC cases (0.79%) with MET alterations (4 point mutation events and 9 focal amplification events). MET-mutant or amplified tumors represent a small but potentially actionable molecular subset of HNSCC. KEY POINTS: This case report is believed to be the first reported pan-cancer case of a patient harbori...Continue Reading

References

Jan 7, 2006·Cancer Research·Monica Kong-BeltranRobert Yauch
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shailaja Kalyankrishna, Jennifer R Grandis
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C SokJennifer R Grandis
Nov 3, 2006·Experimental & Molecular Medicine·Jae-Ho LeeGeorge F Vande Woude
Dec 21, 2007·The New England Journal of Medicine·M Luana PoetaWayne M Koch
Apr 3, 2008·Mayo Clinic Proceedings·Shanthi Marur, Arlene A Forastiere
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Jun 18, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Christel Braemer Lajer, Christian von Buchwald
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Jul 30, 2011·Science·Nicolas StranskyJennifer R Grandis
Nov 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jochen K LennerzA John Iafrate
May 4, 2012·Archives of Pharmacal Research·Kyung Hee JungSoon-Sun Hong
Feb 22, 2013·International Journal of Oncology·Hiroaki KatoKazuto Nishio
Jan 30, 2015·Nature·UNKNOWN Cancer Genome Atlas Network
May 15, 2015·JAMA Otolaryngology-- Head & Neck Surgery·Alexander L LuryiBenjamin L Judson
Nov 9, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yosuke TogashiTetsuya Mitsudomi
Dec 8, 2015·American Journal of Human Genetics·Mary J GrayStephen P Robertson
Jun 28, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alexa B SchrockSai-Hong Ignatius Ou
Sep 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rafael CaparicaGilberto de Castro
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Dec 28, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Thanyanan ReungwetwattanaSai-Hong Ignatius Ou
Jul 12, 2018·Scientific Reports·Vit VsianskyMichal Masarik
Mar 1, 2019·Frontiers in Oncology·Esma Saada-Bouzid, Christophe Le Tourneau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.